140 related articles for article (PubMed ID: 31404331)
21. [Negative symptoms predict the improvement of social functioning of patients with schizophrenia].
He Q; Chen Y; Chow SL; Huang MM; Zhang ZQ; Zhang SS; Shen WW; Deng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):284-8. PubMed ID: 24749359
[TBL] [Abstract][Full Text] [Related]
22. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.
Ciudad A; Olivares JM; Bousoño M; Gómez JC; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1515-22. PubMed ID: 16820255
[TBL] [Abstract][Full Text] [Related]
23. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
[TBL] [Abstract][Full Text] [Related]
24. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
25. [Insight and social functioning in deficit and nondeficit schizophrenia].
Köşger F; Şahin H; Eşsizoğlu A; Aksaray G
Turk Psikiyatri Derg; 2014; 25(3):157-62. PubMed ID: 25219689
[TBL] [Abstract][Full Text] [Related]
26. Apathy, cognitive deficits and functional impairment in schizophrenia.
Konstantakopoulos G; Ploumpidis D; Oulis P; Patrikelis P; Soumani A; Papadimitriou GN; Politis AM
Schizophr Res; 2011 Dec; 133(1-3):193-8. PubMed ID: 21788116
[TBL] [Abstract][Full Text] [Related]
27. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
[TBL] [Abstract][Full Text] [Related]
28. Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
Rocca P; Montemagni C; Zappia S; Piterà R; Sigaudo M; Bogetto F
Psychiatry Res; 2014 Aug; 218(3):284-9. PubMed ID: 24814140
[TBL] [Abstract][Full Text] [Related]
29. Asocial beliefs as predictors of asocial behavior in schizophrenia.
Grant PM; Beck AT
Psychiatry Res; 2010 May; 177(1-2):65-70. PubMed ID: 20163875
[TBL] [Abstract][Full Text] [Related]
30. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.
Patrick DL; Burns T; Morosini P; Rothman M; Gagnon DD; Wild D; Adriaenssen I
Curr Med Res Opin; 2009 Feb; 25(2):325-38. PubMed ID: 19192977
[TBL] [Abstract][Full Text] [Related]
31. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.
Hunter R; Barry S
Eur Psychiatry; 2012 Aug; 27(6):432-6. PubMed ID: 21602034
[TBL] [Abstract][Full Text] [Related]
32. Improving social functioning in schizophrenia by playing the train game.
Torres A; Mendez LP; Merino H; Moran EA
Psychiatr Serv; 2002 Jul; 53(7):799-801. PubMed ID: 12096159
[TBL] [Abstract][Full Text] [Related]
33. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
[TBL] [Abstract][Full Text] [Related]
34. Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: An open-label, single-arm, flexible-dose, 12-months follow-up study.
Üçok A; Saka MC; Bilici M
Nord J Psychiatry; 2015 Aug; 69(6):426-32. PubMed ID: 25549697
[TBL] [Abstract][Full Text] [Related]
35. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
Favrod J; Ernst F; Giuliani F; Bonsack C
Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
[TBL] [Abstract][Full Text] [Related]
36. Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia.
Cicero DC; Klaunig MJ; Trask CL; Neis AM
Schizophr Res; 2016 Oct; 176(2-3):456-461. PubMed ID: 27562615
[TBL] [Abstract][Full Text] [Related]
37. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
[TBL] [Abstract][Full Text] [Related]
38. [Facial emotion recognition in patients with recurrent depressive disorder and patients with schizophrenia].
Okruszek L; Talarowska M; Schudy A; Skrodzka M
Pol Merkur Lekarski; 2014 Aug; 37(218):99-103. PubMed ID: 25252444
[TBL] [Abstract][Full Text] [Related]
39. Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs.
Granholm E; Holden J; Worley M
Schizophr Bull; 2018 Apr; 44(3):653-661. PubMed ID: 29036391
[TBL] [Abstract][Full Text] [Related]
40. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
Mach C; Dollfus S
Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
